Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver Disease
1 other identifier
observational
4,000
1 country
1
Brief Summary
Excessive or insufficient levels of vitamins in the body can affect health. With the prevalence of obesity and MetS, NAFLD has become the leading cause of chronic liver disease and abnormal liver biochemical indicators in health examinations in China. The current research results on serum vitamin A, D, and E levels in NAFLD patients are controversial. Therefore, this study mainly explores the correlation between serum FSV levels and NAFLD, providing reference for nutrition and clinical management of NAFLD patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 3, 2024
CompletedFirst Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
July 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 10, 2026
July 22, 2024
July 1, 2024
2 years
July 10, 2024
July 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
non-alcoholic fatty liver disease prevanlence
Day 1
serum vitamin A
Day 1
serum vitamin D
Day 1
serum vitamin E
Day 1
serum vitamin k
Day 1
Eligibility Criteria
Adults aged 18 and above who underwent physical examinations at the Health Management Center of the First Affiliated Hospital of Zhejiang University School of Medicine from July 2024 to June 2026.
You may qualify if:
- Age ≥ 18 years old, both male and female;
- Voluntarily participate in this study and sign an informed consent form;
- Diagnosed NAFLD through abdominal ultrasound;
You may not qualify if:
- Acute and chronic infections, severe cardiovascular and cerebrovascular diseases, respiratory system diseases, urinary system diseases, rheumatic diseases, tumors, and pituitary dysfunction; Or have hepatitis B, hepatitis C virus, or acquired immunodeficiency syndrome;
- Surgery was performed within 6 months, and blood donation, transfusion, or significant blood loss occurred within 4 months;
- Have taken vitamin supplements within 2 weeks;
- Women are in pregnancy, lactation, or within one year after childbirth;
- Alcohol abuse (alcohol intake ≥ 140 g/week for males and ≥ 70 g/week for females)
- The serum creatinine (SCr) exceeds twice the following abnormal values, with the standard of abnormal values being: male (20-59 years old)\>97 μ mol/L, male (60-79 years old)\>111 μ mol/L; Female (20-59 years old)\>73 μ mol/L, female (60-79 years old)\>81 μ mol/L.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, 310003, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhong Liu, MD
First Affiliated Hospital of Zhejiang University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
July 10, 2024
First Posted
July 22, 2024
Study Start
July 3, 2024
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 10, 2026
Last Updated
July 22, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share